Post-Vendor Selection
Evaluating research platform capabilities for specific life sciences use cases can be complex, and challenges often persist when the software is implemented due to a lack of time, personnel, and in-house expertise.
Our consultants are Benchling specialists, which means we can provide strategic guidance and continually support your Benchling ecosystem according to both your short-term and long-term goals. This can include creating training tailored for your specific use cases to support user adoption and providing insights into effective change management strategies to help communicate the value the new platform can provide to their daily work.
End-to-End Benchling Solutions
We have extensive experience supporting Benchling end-to-end solutions for the following:
Protein-based Therapy
- Monoclonal antibodies
- Bispecific antibodies
- Fusion proteins
Cell Therapy
- CAR-T generation
- CAR-NK generation
- Macrophage modulation
Gene Therapy
- CRISPR
- Coding RNA
- Non-coding RNA
Trusted Benchling Partner
Our combination of scientific knowledge, hands-on laboratory research, and technology expertise allows us to truly understand your needs and help ensure data protection, integrity, and utility. This agile and scalable approach enables us to deliver customized services that optimize results.
Our managed Benchling services can include:
Project scoping, requirements gathering, document generation, and overall system assessment
Ongoing data governance, maintenance, and support of test and production environments
Data model configuration changes and refreshes
Office hours for users to ask questions, receive support, and gain knowledge of the platform
Generating client-tailored training materials, customized for your specific use cases, to help ensure your team is using the Benchling platform to its fullest potential
Custom Managed Benchling Services
Contact us today to learn more about our Benchling services or speak with one of our experts.
Benchling Experts
-
Warren Vieira
Senior R&D Technology Manager
View Bio
-
Jenny Dao
Solutions Consultant
View Bio
News & Insights
July 28, 2025
Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market
Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...
July 25, 2025
Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...
Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).
July 24, 2025
FDA Publishes over 200 Complete Response Letters (CRLs)
FDA's new transparency with over 200 CRLs empowers sponsors to navigate regulatory challenges more effectively, accelerating drug approvals and enhancing patient access to treatments.
.png?width=320&height=185&name=Obesity%20%E2%80%93%20Accelerated%20Timelines%20(1).png)
.png?width=320&height=185&name=labeling-webinar-thumbnail%20(1).png)
News & Insights
July 8, 2025
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
